Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.
Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease.
Last year, Tuatara and its affiliates invested $7.0 million in a Series A Financing for the company. The Sichenzia Ross Ference Kesner LLP team was led by partners Darrin M. Ocasio and Arthur Marcus and associate S. Ashley Jaber. Sichenzia Ross Ference Kesner LLP is a leader in the representation of cannabis related companies.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition - February 14, 2019
- Sichenzia Ross Ference Partner Ralph Preite Participates on Financial Poise’s “Legal Ethics – Best Practices” Webinar - February 14, 2019
- Sichenzia Ross Ference LLP Adds Jeff D’Angelo as Corporate & Securities Partner - February 13, 2019